Covered by NYDaily News. Las Vegas man accused of threatening a prominent attorney and making vile remarks.
Covered by New York Times, and other outlets. Fake heiress accused of conning the city’s wealthy, and has an HBO special being made about her.
Accused of stalking Alec Baldwin. The case garnered nationwide attention, with USAToday, NYPost, and other media outlets following it closely.
Juror who prompted calls for new Ghislaine Maxwell trial turns to lawyer who defended Anna Sorokin.
Clients can use our portal to track the status of their case, stay in touch with us, upload documents, and more.
Regardless of the type of situation you're facing, our attorneys are here to help you get quality representation.
We can setup consultations in person, over Zoom, or over the phone to help you. Bottom line, we're here to help you win your case.
The Spodek Law Group understands how delicate high-profile cases can be, and has a strong track record of getting positive outcomes. Our lawyers service a clientele that is nationwide. With offices in both LA and NYC, and cases all across the country - Spodek Law Group is a top tier law firm.
Todd Spodek is a second generation attorney with immense experience. He has many years of experience handling 100’s of tough and hard to win trials. He’s been featured on major news outlets, such as New York Post, Newsweek, Fox 5 New York, South China Morning Post, Insider.com, and many others.
In 2022, Netflix released a series about one of Todd’s clients: Anna Delvey/Anna Sorokin.
Why Clients Choose Spodek Law Group
The reason is simple: clients want white glove service, and lawyers who can win. Every single client who works with the Spodek Law Group is aware that the attorney they hire could drastically change the outcome of their case. Hiring the Spodek Law Group means you’re taking your future seriously. Our lawyers handle cases nationwide, ranging from NYC to LA. Our philosophy is fair and simple: our nyc criminal lawyers only take on clients who we know will benefit from our services.
We’re selective about the clients we work with, and only take on cases we know align with our experience – and where we can make a difference. This is different from other law firms who are not invested in your success nor care about your outcome.
If you have a legal issue, call us for a consultation.
We are available 24/7, to help you with any – and all, challenges you face.
Last Updated on: 26th July 2023, 08:28 pm
Imagine this: you’re at the helm of a pharmacy operation and unexpectedly, you’re served with an Admonitory Letter from the Drug Enforcement Authority (DEA). Understandably, your heart skips a beat. Consequences, varying in gravity from a light slap on the wrist to a federal sentence with steep monetary penalties, can ensue from a DEA inspection.
This foreboding dispatch from the DEA comes when their eagle-eyed scrutiny detects minor discrepancies in your record-keeping system. Though not an immediate precursor to a legal skirmish, it’s not an issue to be tossed aside nonchalantly.
The DEA auditors, armed with their vast experience, have sensed a potential discordance between your pharmacy’s modus operandi and the DEA’s prescribed norms. This indicates that your compliance model needs a swift and thorough revamp. Such an admonition is a stern reminder that procrastination can be a perilous gamble with escalating repercussions during subsequent audits.
Akin to a formally issued chastisement, the Admonitory Letter serves as a clear harbinger of compliance deficiencies that must be rectified ahead of the next audit. This course of action by the DEA, though the least stringent, is a well-intentioned nudge towards constructive change.
The letter elucidates the perceived transgressions – perhaps a lapse in maintaining requisite program documents, inadequate personnel training, or a rather lax record-keeping procedure. The latter could encompass a gamut of areas: prescription order management, inventory upkeep, waste disposal, and even liaisons with referring physicians, to name a few. Your billing practices with Medicare, Medicaid, or VA might also instigate the dispatch of such a letter.
Although the Admonitory Letter imposes no mandatory response or immediate penalties, a grave breach of DEA guidelines could usher in serious legal ramifications. Ignoring this advisory missive could be the harbinger of dire future actions.
The receipt of an Admonitory Letter should spur you into action. Here is a five-step plan to navigate the aftermath:
Revamp your policies and procedures: This indicates to the DEA that you have heeded their advice and are dedicated to ensuring compliance.
Address the highlighted issues: Turning a blind eye to the letter is a suboptimal strategy. Unresolved issues, whether related to compliance, training, or record-keeping, can exacerbate over time, possibly trickling down to new recruits.
Understand the long-term implications: The Admonitory Letter becomes a part of your DEA dossier, potentially complicating future certifications and audits. The loss of your DEA license would shut down your pharmacy operations, impacting not just your bottom line, but also the livelihoods of your employees.
Initiate an internal audit: An experienced manager, a team, or a third party could conduct this. Make this a recurrent practice to swiftly spot and rectify any shortcomings.
Implement a vigilant monitoring program: A well-oiled monitoring system can detect infractions almost instantaneously, enabling quick course correction. Persistent offenders may require additional training. Documented corrective actions demonstrate your proactive approach.
Please fill out the form below to receive a free consultation, we will respond to
your inquiry within 24-hours guaranteed.